URETHRAL CANCER
Clinical trials for URETHRAL CANCER explained in plain language.
Never miss a new study
Get alerted when new URETHRAL CANCER trials appear
Sign up with your email to follow new studies for URETHRAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat cancers: drug shows promise in advanced HER2-positive tumors
Disease control Recruiting nowThis study looks at how well the drug T-DXd works in adults with advanced HER2-positive cancers that have spread and no longer respond to other treatments. About 100 people will take part, and researchers will track whether tumors shrink and how long the benefit lasts. The goal i…
Matched conditions: URETHRAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Massive cancer registry aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is creating a huge collection of medical information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. The goal is to help researchers better understand cancer causes, improve early detection, and develop person…
Matched conditions: URETHRAL CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
New PET tracer could reveal which tumors respond to immunotherapy
Knowledge-focused Recruiting nowThis study tests a new radioactive tracer called 64Cu-GRIP B, which attaches to a protein (granzyme B) made by immune cells. By using PET scans, doctors hope to see which tumors are responding to immunotherapy. The trial involves about 91 adults with advanced prostate, kidney, or…
Matched conditions: URETHRAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Rahul Aggarwal • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC